Carol A. Wang

Carol A. Wang

Auto-generated profile, based on publicly available information

Carol A. Wang

School of Medicine and Public Health, University of Newcastle, Australia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2021 in Nature
Verified
Journal Article
Closed access
PDF file
SGSarah E. Graham
Sarah E. Graham
SCShoa L. Clarke
Shoa L. Clarke
KWKuan-Han H. Wu
Kuan-Han H. Wu
Stavroula KanoniStavroula Kanoni
Stavroula Kanoni
GZGreg J. M. Zajac
Greg J. M. Zajac
CWCristen J. Willer
Cristen J. Willer

1 May 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ECEGG Consortium
EGG Consortium
NWNicole M. Warrington
Nicole M. Warrington
RBRobin N. Beaumont
Robin N. Beaumont
MHMomoko Horikoshi
Momoko Horikoshi
FDFelix R. Day
Felix R. Day
RFRachel M. Freathy
Rachel M. Freathy

1 February 2017 in Nature
Verified
Journal Article
Open access
PDF file
EMEirini Marouli
Eirini Marouli
MGMariaelisa Graff
Mariaelisa Graff
CGCarolina Medina Gomez
Carolina Medina Gomez
KLKen Sin Lo
Ken Sin Lo
AWAndrew R. Wood
Andrew R. Wood
GLGuillaume Lettre
Guillaume Lettre
Height is a highly heritable, classic polygenic trait with approximately 700 common associated variants identified through genome-wide association studies so far. Here, we report 83 height-associated coding variants with lower minor-allele frequencies (in the range of 0.1–4.8%) and effects of up to 2 centimetres per allele (such as those in IHH, STC2, AR and CRISPLD2), greater than ten times the average effect of common variants. In functional follow-up studies, rare height-increasing alleles of STC2 (giving an increase of 1–2 centimetres per allele) compromised proteolytic inhibition of PAPP-A and increased cleavage of IGFBP-4 in vitro, resulting in higher bioavailability of insulin-like growth factors. These 83 height-associated variants overlap genes that are mutated in monogenic growth disorders and highlight new biological candidates (such as ADAMTS3, IL11RA and NOX4) and pathways (such as proteoglycan and glycosaminoglycan synthesis) involved in growth. Our results demonstrate that sufficiently large sample sizes can uncover rare and low-frequency variants of moderate-to-large effect associated with polygenic human phenotypes, and that these variants implicate relevant genes and pathways.

6 September 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JMJosine L. Min
Josine L. Min
GHGibran Hemani
Gibran Hemani
EHEilis Hannon
Eilis Hannon
KDKoen F. Dekkers
Koen F. Dekkers
JCJuan Castillo-Fernandez
Juan Castillo-Fernandez
CRCaroline L. Relton
Caroline L. Relton

28 September 2016 in Nature
Verified
Journal Article
Closed access
PDF file
CGCHARGE Consortium Hematology Working Group
CHARGE Consortium Hematology Working Group
MHMomoko Horikoshi
Momoko Horikoshi
ECEarly Growth Genetics (EGG) Consortium
Early Growth Genetics (EGG) Consortium
RBRobin N. Beaumont
Robin N. Beaumont
FDFelix R. Day
Felix R. Day
RFRachel M. Freathy
Rachel M. Freathy

22 December 2017 in Nature Genetics
Verified
Journal Article
Open access
PDF file
VTValérie Turcot
Valérie Turcot
YLYingchang Lu
Yingchang Lu
HHHeather M. Highland
Heather M. Highland
CSClaudia Schurmann
Claudia Schurmann
AJAnne E. Justice
Anne E. Justice
RLRuth J. F. Loos
Ruth J. F. Loos
Genome-wide association studies (GWAS) have identified >250 loci for body mass index (BMI), implicating pathways related to neuronal biology. Most GWAS loci represent clusters of common, noncoding variants from which pinpointing causal genes remains challenging. Here we combined data from 718,734 individuals to discover rare and low-frequency (minor allele frequency (MAF) < 5%) coding variants associated with BMI. We identified 14 coding variants in 13 genes, of which 8 variants were in genes (ZBTB7B, ACHE, RAPGEF3, RAB21, ZFHX3, ENTPD6, ZFR2 and ZNF169) newly implicated in human obesity, 2 variants were in genes (MC4R and KSR2) previously observed to be mutated in extreme obesity and 2 variants were in GIPR. The effect sizes of rare variants are ~10 times larger than those of common variants, with the largest effect observed in carriers of an MC4R mutation introducing a stop codon (p.Tyr35Ter, MAF = 0.01%), who weighed ~7 kg more than non-carriers. Pathway analyses based on the variants associated with BMI confirm enrichment of neuronal genes and provide new evidence for adipocyte and energy expenditure biology, widening the potential of genetically supported therapeutic targets in obesity.